Fragmented and Poorly Executed- the Failed Potential of mRNA Vaccine Therapeutic Platform

has taken Pfizer nearly 2 years to publish a paper showing any data regarding whether the mRNA is actually made into a protein product. Two years!!! This work should have been available before the emergency use authorization (EUA) was granted for the vaccines. Unfortunately, none of the basic bench-to-bedside work was submitted for…

--

--

Dr. Aditi Bhargava is a molecular neuroendocrinologist with research focus on sex differences in stress biology and immunology.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Aditi Bhargava

Dr. Aditi Bhargava is a molecular neuroendocrinologist with research focus on sex differences in stress biology and immunology.